Literature DB >> 12647939

Economic analysis of the Confronting COPD survey: methodology.

M T Halpern1, A Musin, S Sondhi.   

Abstract

Chronic obstructive pulmonary disease (COPD) is a condition characterized by progressive airflow limitation, which causes considerable morbidity and mortality worldwide. Yet the burden of COPD is poorly recognized, and the disease remains an inadequately managed health problem. Few studies have attempted to quantify the impact of the disease on patient health, the healthcare system and society as a whole. This provided the rationale for Confronting COPD in North America and Europe, the first large-scale international survey of the burden of COPD. This paper describes how quantitative measures of healthcare resource utilization and workplace productivity loss were derived from patient responses to the Confronting COPD survey, to investigate the country-specific impact of COPD on the healthcare system and society. The aim of this analysis is to inform countries of the economic impact of the condition, and demonstrate the need for better COPD treatment to improve health and reduce the sizeable burden of this disease.

Entities:  

Mesh:

Year:  2003        PMID: 12647939     DOI: 10.1016/s0954-6111(03)80021-5

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  3 in total

Review 1.  Cost-of-illness studies : a review of current methods.

Authors:  Ebere Akobundu; Jing Ju; Lisa Blatt; C Daniel Mullins
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

2.  Practice patterns in the management of chronic obstructive pulmonary disease in primary practice: the CAGE study.

Authors:  J Bourbeau; R J Sebaldt; A Day; J Bouchard; A Kaplan; P Hernandez; M Rouleau; A Petrie; G Foster; L Thabane; J Haddon; A Scalera
Journal:  Can Respir J       Date:  2008 Jan-Feb       Impact factor: 2.409

3.  Implementing practice guidelines: a workshop on guidelines dissemination and implementation with a focus on asthma and COPD.

Authors:  Louis-Philippe Boulet; Allan Becker; Dennis Bowie; Paul Hernandez; Andrew McIvor; Michel Rouleau; Jean Bourbeau; Ian D Graham; Jo Logan; France Légaré; Thomas F Ward; Robert L Cowie; Denis Drouin; Stewart B Harris; Robyn Tamblyn; Pierre Ernst; Wan C Tan; Martyn R Partridge; Philippe Godard; Carla T Herrerias; John W Wilson; Liz Stirling; Emily-Brynn Rozitis; Nancy Garvey; Diane Lougheed; Manon Labrecque; Renata Rea; Martin C Holroyde; Danielle Fagnan; Eileen Dorval; Lisa Pogany; Alan Kaplan; Lisa Cicutto; Mary L Allen; Serge Moraca; J Mark FitzGerald; Francine Borduas
Journal:  Can Respir J       Date:  2006-03       Impact factor: 2.409

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.